간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
의료 미학 시장. 의료 미학 시장 규모는 2027 년까지 183 억 달러에 달하는 것으로 추정됩니다. 또한 2022-2027 년 예측 기간 동안 9.2%의 CAGR에서 성장할 준비가되어 있습니다
Summary
Medical Aesthetics Market. The Medical Aesthetics Market size is estimated to reach $18.3 billion by 2027. Furthermore, it is poised to grow at a CAGR of 9.2% over the forecast period of 2022-2027
Table of Contents
1. Medical Aesthetics Market Overview
1.1 Definitions and Scope
2. Medical Aesthetics Market- Executive Summary
3. Medical Aesthetics Market– Market Landscape
3.1 Company Benchmarking- Key Companies
3.2 Key Company Financial Analysis
3.3 Market Share Analysis
3.4 Patent Analysis
3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Medical Aesthetics Market- Market Forces
4.1 Market Drivers
4.2 Market Constraints
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Medical Aesthetics Market– By Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle Analysis
6. Medical Aesthetics Market- By Product/Service (Market Size –$Million/$Billion)
6.1 Facial Aesthetics Products
6.1.1 Dermal Fillers
6.1.2 Botulinum Toxins
6.1.3 Microdermabrasion
6.1.4 Chemical Peels
6.1.5 Others
6.2 Body Contouring Devices
6.2.1 Non-Surgical Fat Reduction Devices
6.2.2 Cellulite Reduction Devices
6.2.3 Liposuction Devices
6.2.4 Others
6.3 Cosmetic Implants
6.3.1 Breast Implants and Removal
6.3.2 Facial Implants
6.3.3 Gluteal Implants
6.3.4 Others
6.4 Hair Removal Devices
6.4.1 Laser Hair Removal Devices
6.4.2 Non-Surgical Skin Tightening Devices
6.4.3 Micro-needling Products
6.4.4 Light Therapy Devices
6.4.5 Others
6.5 Tattoo Removal Devices
6.6 Thread Lift Products
6.7 Nail Treatment Laser Devices
7. Medical Aesthetics Market- By Service Providers (Market Size –$Million/$Billion)
7.1 Beauty Centers
7.2 Clinical-Hospital-Medical SPAs
7.3 Home-Care
7.4 Others
8. Medical Aesthetics Market- By Geography (Market Size -$Million/Billion)
8.1 North America
8.1.1 U.S
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 UK
8.2.4 Italy
8.2.5 Spain
8.2.6 Russia
8.2.7 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 Rest of APAC
8.4 South America
8.4.1 Brazil
8.4.2 Argentina
8.4.3 Chile
8.4.4 Colombia
8.4.5 Rest of South America
8.5 Rest of the World
8.5.1 Middle East
8.5.2 Africa
9. Medical Aesthetics Market- Market Entropy
9.1 New product launches
9.2 M&A's, collaborations, JVs and partnerships
10. Medical Aesthetics Market- Company Analysis
10.1 Company 1
10.2 Company 2
10.3 Company 3
10.4 Company 4
10.5 Company 5
10.6 Company 6
10.7 Company 7
10.8 Company 8
10.9 Company 9
10.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies*"
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
의료 미학 시장. 의료 미학 시장 규모는 2027 년까지 183 억 달러에 달하는 것으로 추정됩니다. 또한 2022-2027 년 예측 기간 동안 9.2%의 CAGR에서 성장할 준비가되어 있습니다
Summary
Medical Aesthetics Market. The Medical Aesthetics Market size is estimated to reach $18.3 billion by 2027. Furthermore, it is poised to grow at a CAGR of 9.2% over the forecast period of 2022-2027
Table of Contents
1. Medical Aesthetics Market Overview
1.1 Definitions and Scope
2. Medical Aesthetics Market- Executive Summary
3. Medical Aesthetics Market– Market Landscape
3.1 Company Benchmarking- Key Companies
3.2 Key Company Financial Analysis
3.3 Market Share Analysis
3.4 Patent Analysis
3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Medical Aesthetics Market- Market Forces
4.1 Market Drivers
4.2 Market Constraints
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Medical Aesthetics Market– By Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle Analysis
6. Medical Aesthetics Market- By Product/Service (Market Size –$Million/$Billion)
6.1 Facial Aesthetics Products
6.1.1 Dermal Fillers
6.1.2 Botulinum Toxins
6.1.3 Microdermabrasion
6.1.4 Chemical Peels
6.1.5 Others
6.2 Body Contouring Devices
6.2.1 Non-Surgical Fat Reduction Devices
6.2.2 Cellulite Reduction Devices
6.2.3 Liposuction Devices
6.2.4 Others
6.3 Cosmetic Implants
6.3.1 Breast Implants and Removal
6.3.2 Facial Implants
6.3.3 Gluteal Implants
6.3.4 Others
6.4 Hair Removal Devices
6.4.1 Laser Hair Removal Devices
6.4.2 Non-Surgical Skin Tightening Devices
6.4.3 Micro-needling Products
6.4.4 Light Therapy Devices
6.4.5 Others
6.5 Tattoo Removal Devices
6.6 Thread Lift Products
6.7 Nail Treatment Laser Devices
7. Medical Aesthetics Market- By Service Providers (Market Size –$Million/$Billion)
7.1 Beauty Centers
7.2 Clinical-Hospital-Medical SPAs
7.3 Home-Care
7.4 Others
8. Medical Aesthetics Market- By Geography (Market Size -$Million/Billion)
8.1 North America
8.1.1 U.S
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 UK
8.2.4 Italy
8.2.5 Spain
8.2.6 Russia
8.2.7 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 Rest of APAC
8.4 South America
8.4.1 Brazil
8.4.2 Argentina
8.4.3 Chile
8.4.4 Colombia
8.4.5 Rest of South America
8.5 Rest of the World
8.5.1 Middle East
8.5.2 Africa
9. Medical Aesthetics Market- Market Entropy
9.1 New product launches
9.2 M&A's, collaborations, JVs and partnerships
10. Medical Aesthetics Market- Company Analysis
10.1 Company 1
10.2 Company 2
10.3 Company 3
10.4 Company 4
10.5 Company 5
10.6 Company 6
10.7 Company 7
10.8 Company 8
10.9 Company 9
10.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies*"
